Use of human NIS protein as an endogenous target is in practice for treatment of thyroid cancer (TC) patients using 131I.6Physiologically, out of the vast number of solute carrier family of proteins, NIS is the sole candidate responsible for inward transportation of iodide ions in thyroid follicular cells, a requisite for thyroid hormone synthesis. The gene discussed is SLC5A5; the disease is thyroid cancer.